enVVeno Medical Corp Shareholders' Equity
enVVeno Medical Corp (NVNO) had Shareholders' Equity of $20.67 million as of 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-07-30
- 2026-06-30: Stockholders' Equity Attributable to Parent $20.67M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $23.75M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $27.13M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $29.45M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $20.67M 10-Q · filed 2026-07-30 | |
| 2026-03-31 | $23.75M 10-Q · filed 2026-07-30 | |
| 2025-12-31 | $27.13M 10-Q · filed 2026-07-30 | |
| 2025-09-30 | $29.45M 10-Q · filed 2025-10-30 | |
| 2025-06-30 | $33.06M 10-Q · filed 2026-07-30 | |
| 2025-03-31 | $38.31M 10-Q · filed 2026-07-30 | |
| 2024-12-31 | $42.16M 10-Q · filed 2026-07-30 | |
| 2024-09-30 | $47.37M 10-Q · filed 2025-10-30 | |
| 2024-06-30 | $38.42M 10-Q · filed 2025-10-30 | |
| 2024-03-31 | $42.37M 10-Q · filed 2025-07-31 | |
| 2023-12-31 | $46.20M 10-K · filed 2026-03-26 | |
| 2023-09-30 | $24.91M 10-Q · filed 2024-10-31 | |
| 2023-06-30 | $28.81M 10-Q · filed 2024-10-31 | |
| 2023-03-31 | $34.13M 10-Q · filed 2024-07-31 | |
| 2022-12-31 | $38.73M 10-K · filed 2025-02-28 | |
| 2022-09-30 | $42.67M 10-Q · filed 2023-10-26 | |
| 2022-06-30 | $46.56M 10-Q · filed 2023-10-26 | |
| 2022-03-31 | $51.32M 10-Q · filed 2023-07-31 | |
| 2021-12-31 | $54.40M 10-K · filed 2024-02-29 | $54.40M 10-K · filed 2022-03-28 |
| 2021-09-30 | $58.05M 10-Q · filed 2022-10-27 | $58.05M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $40.87M 10-Q · filed 2022-10-27 | $40.87M 10-Q · filed 2021-08-11 |
| 2021-03-31 | $43.01M 10-Q · filed 2022-10-27 | $43.01M 10-Q · filed 2021-05-12 |
| 2020-12-31 | $7.10M 10-K · filed 2023-03-02 | $7.10M 10-K · filed 2021-03-31 |
| 2020-09-30 | $4.79M 10-Q · filed 2021-11-12 | |
| 2020-06-30 | $369.45K 10-Q · filed 2021-11-12 | $369.44K 10-Q · filed 2020-08-14 |
| 2020-03-31 | -$14.62K 10-Q · filed 2021-11-12 | |
| 2019-12-31 | $989.94K 10-K · filed 2022-03-28 | |
| 2019-09-30 | $3.08M 10-Q · filed 2020-11-17 | |
| 2019-06-30 | $4.65M 10-Q · filed 2020-11-17 | |
| 2019-03-31 | $2.87M 10-Q · filed 2020-11-17 | |
| 2018-12-31 | $2.04M 10-K · filed 2021-03-31 | |
| 2018-09-30 | $3.54M 10-Q · filed 2019-10-31 | |
| 2018-06-30 | $4.61M 10-Q · filed 2019-10-31 | |
| 2018-03-31 | -$15.74M 10-Q · filed 2019-10-31 | |
| 2017-12-31 | -$11.13M 10-K · filed 2020-03-18 | |
| 2016-12-31 | -$4.22M 10-K · filed 2019-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |